In this Lupus & You recording, medical experts and guest speakers share insights that challenge the misconception that lupus only affects women. Learn about the experiences of men living with lupus, ...

Help raise lupus awareness during the Virtual 6 Challenge by sharing your story. Here is some inspiration to get you started. If you are taking the extra step and fundraising, don't forget to include ...

Gazyva has also been filed for the lupus nephritis indication in Europe, said Roche, which is also expecting a readout from the phase 3 ALLEGORY trial in a broader SLE population later in 2025 and ...

UCB and Biogen say their first phase 3 trial of their systemic lupus erythematosus (SLE) candidate dapirolizumab pegol was a success, and a second is now expected to start before the end of the year.

Early signs of lupus in females, such as fatigue, joint pain, and rashes, are commonly mistaken for symptoms of other conditions. Lupus is an autoimmune disease that's far more common in females than ...

Objective Both belimumab and telitacicept are recognised blockers for B lymphocyte activation, both of which have been approved as add-on therapies for SLE in China. The aim of this study is to ...

The proportion of patients with lupus nephritis (LN) was 2.8%, which may be lower than the proportion of belimumab-treated patients with LN currently. However, the study period concluded in 2019 ...